[{"address1": "680 East Colorado Boulevard", "address2": "Suite 180", "city": "Pasadena", "state": "CA", "zip": "91101", "country": "United States", "phone": "631 830 7092", "fax": "631 982 5050", "website": "https://lixte.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. Bastiaan  van der Baan M.Sc.", "age": 52, "title": "President, Chief Scientific Officer & Director", "yearBorn": 1972, "fiscalYear": 2023, "totalPay": 172784, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert Neal Weingarten", "age": 72, "title": "CFO, VP & Secretary", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 175000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Geordan G. Pursglove", "age": 36, "title": "CEO & Chairman", "yearBorn": 1988, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 4.875, "open": 4.78, "dayLow": 4.42, "dayHigh": 4.94, "regularMarketPreviousClose": 4.875, "regularMarketOpen": 4.78, "regularMarketDayLow": 4.42, "regularMarketDayHigh": 4.94, "payoutRatio": 0.0, "volume": 79374, "regularMarketVolume": 79374, "averageVolume": 2092837, "averageVolume10days": 136070, "averageDailyVolume10Day": 136070, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 14621327, "fiftyTwoWeekLow": 0.64, "fiftyTwoWeekHigh": 5.14, "fiftyDayAverage": 2.5834, "twoHundredDayAverage": 1.91095, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 21144172, "profitMargins": 0.0, "floatShares": 4310944, "sharesOutstanding": 3027190, "sharesShort": 122174, "sharesShortPriorMonth": 4456, "sharesShortPreviousMonthDate": 1749772800, "dateShortInterest": 1752537600, "sharesPercentSharesOut": 0.0404, "heldPercentInsiders": 0.108459994, "heldPercentInstitutions": 0.06949, "shortRatio": 0.02, "shortPercentOfFloat": 0.040900003, "impliedSharesOutstanding": 3027190, "bookValue": 0.236, "priceToBook": 20.4661, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -3088952, "trailingEps": -1.45, "lastSplitFactor": "1:10", "lastSplitDate": 1685923200, "52WeekChange": 1.278302, "SandP52WeekChange": 0.19554341, "quoteType": "EQUITY", "currentPrice": 4.83, "recommendationKey": "none", "totalCash": 887212, "totalCashPerShare": 0.195, "totalDebt": 0, "quickRatio": 1.652, "currentRatio": 1.843, "returnOnAssets": -0.99791, "returnOnEquity": -2.1320798, "freeCashflow": -1426660, "operatingCashflow": -2612238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "LIXT", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Lixte Biotechnology Holdings, I", "longName": "Lixte Biotechnology Holdings, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1193319000000, "postMarketChangePercent": -0.414078, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1754696895, "regularMarketTime": 1754683201, "exchange": "NCM", "messageBoardId": "finmb_29181356", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -0.923079, "regularMarketPrice": 4.83, "postMarketPrice": 4.81, "postMarketChange": -0.02, "regularMarketChange": -0.0450001, "regularMarketDayRange": "4.42 - 4.94", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2092837, "fiftyTwoWeekLowChange": 4.19, "fiftyTwoWeekLowChangePercent": 6.546875, "fiftyTwoWeekRange": "0.64 - 5.14", "fiftyTwoWeekHighChange": -0.30999994, "fiftyTwoWeekHighChangePercent": -0.060311273, "fiftyTwoWeekChangePercent": 127.83019, "dividendDate": 1605830400, "earningsTimestamp": 1747053000, "earningsTimestampStart": 1754510400, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.45, "fiftyDayAverageChange": 2.2466, "fiftyDayAverageChangePercent": 0.86962914, "twoHundredDayAverageChange": 2.91905, "twoHundredDayAverageChangePercent": 1.5275387, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "displayName": "Lixte Biotechnology", "trailingPegRatio": null, "__fetch_time": "2025-08-09"}]